• Consensus Rating: Buy
  • Consensus Price Target: $372.39
  • Forecasted Upside: 92.46 %
  • Number of Analysts: 19
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 18 Buy Ratings
  • 0 Strong Buy Ratings
$193.49
▼ -5.07 (-2.55%)

This chart shows the closing price for MDB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MongoDB Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDB

Analyst Price Target is $372.39
▲ +92.46% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for MongoDB in the last 3 months. The average price target is $372.39, with a high forecast of $630.00 and a low forecast of $190.00. The average price target represents a 92.46% upside from the last price of $193.49.

This chart shows the closing price for MDB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 19 contributing investment analysts is to buy stock in MongoDB. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 14 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 15 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/4/2022
  • 0 strong buy ratings
  • 18 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 18 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/2/2022

Latest Recommendations

  • 0 strong buy ratings
  • 18 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/30/2022Truist FinancialInitiated CoverageBuy$300.00Low
9/6/2022The Goldman Sachs GroupLower Target$430.00Low
9/1/2022Canaccord Genuity GroupBoost TargetBuy$300.00 ➝ $360.00Low
9/1/2022Canaccord Genuity GroupBoost TargetBuy ➝ Buy$300.00 ➝ $360.00Low
9/1/2022Needham & Company LLCLower TargetBuy$350.00 ➝ $330.00Low
9/1/2022Stifel NicolausLower TargetBuy ➝ Buy$340.00 ➝ $320.00Low
9/1/2022Robert W. BairdLower TargetOutperform$360.00 ➝ $330.00Low
9/1/2022Royal Bank of CanadaLower TargetOutperform$400.00 ➝ $350.00Low
9/1/2022Credit Suisse GroupLower TargetOutperform$500.00 ➝ $400.00Low
9/1/2022UBS GroupLower TargetBuy$430.00 ➝ $390.00Low
9/1/2022CitigroupLower TargetBuy$450.00 ➝ $445.00Low
9/1/2022BarclaysLower TargetOverweight$438.00 ➝ $360.00Low
9/1/2022Piper SandlerLower TargetOverweight$375.00 ➝ $350.00Low
8/22/2022CitigroupBoost Target$425.00 ➝ $450.00Low
8/17/2022MizuhoBoost TargetBuy$270.00 ➝ $390.00Low
8/16/2022BarclaysBoost TargetOverweight$338.00 ➝ $438.00Low
7/18/2022Piper SandlerLower TargetOverweight$430.00 ➝ $375.00Low
7/12/2022Robert W. BairdInitiated CoverageOutperform$360.00Low
6/29/2022Redburn PartnersInitiated CoverageSell$190.00Low
6/10/2022Needham & Company LLCBoost TargetBuy$310.00 ➝ $350.00High
6/9/2022Royal Bank of CanadaBoost Target$325.00 ➝ $375.00Medium
6/8/2022UBS GroupBoost TargetBuy$315.00 ➝ $345.00Low
6/2/2022Morgan StanleyLower TargetOverweight$378.00 ➝ $368.00High
6/2/2022CitigroupBoost Target$405.00 ➝ $425.00High
6/2/2022Needham & Company LLCLower TargetBuy$362.00 ➝ $310.00High
6/2/2022Stifel NicolausLower Target$425.00 ➝ $340.00High
6/2/2022Canaccord Genuity GroupLower Target$400.00 ➝ $300.00High
6/2/2022Credit Suisse GroupLower TargetOutperform$650.00 ➝ $500.00High
6/2/2022OppenheimerLower TargetOutperform$490.00 ➝ $400.00High
6/2/2022BarclaysBoost TargetOverweight$330.00 ➝ $338.00High
6/2/2022Piper SandlerLower TargetOverweight$585.00 ➝ $430.00High
6/1/2022CitigroupLower TargetBuy$525.00 ➝ $405.00High
5/24/2022William BlairReiterated RatingOutperformHigh
5/20/2022BarclaysLower TargetOverweight$410.00 ➝ $330.00Low
5/19/2022Morgan StanleyLower TargetOverweight$475.00 ➝ $378.00Medium
5/18/2022MizuhoLower TargetNeutral$325.00 ➝ $270.00High
3/18/2022UBS GroupUpgradeNeutral ➝ Buy$345.00 ➝ $450.00High
3/16/2022Morgan StanleyLower TargetOverweight$633.00 ➝ $475.00High
3/9/2022Canaccord Genuity GroupLower Target$560.00 ➝ $400.00High
3/9/2022Stifel NicolausLower Target$550.00 ➝ $425.00High
3/9/2022Needham & Company LLCLower TargetBuy$626.00 ➝ $362.00High
3/9/2022Credit Suisse GroupLower TargetOutperform$700.00 ➝ $650.00High
3/9/2022MizuhoLower TargetNeutral$400.00 ➝ $325.00High
3/9/2022OppenheimerLower Target$510.00 ➝ $410.00High
3/9/2022BarclaysLower TargetOverweight$556.00 ➝ $410.00High
3/1/2022Royal Bank of CanadaInitiated CoverageOutperform$505.00Low
2/15/2022MizuhoLower TargetNeutral$490.00 ➝ $400.00Medium
2/11/2022Tigress FinancialInitiated CoverageBuy$630.00Low
1/12/2022BarclaysLower Target$590.00 ➝ $556.00Medium
12/16/2021Morgan StanleyBoost TargetOverweight$525.00 ➝ $633.00High
12/8/2021The Goldman Sachs GroupBoost TargetBuy$475.00 ➝ $545.00High
12/7/2021Morgan StanleyBoost TargetOverweight ➝ Overweight$480.00 ➝ $525.00High
12/7/2021Stifel NicolausBoost TargetBuy$495.00 ➝ $550.00High
12/7/2021Needham & Company LLCBoost TargetBuy ➝ Buy$534.00 ➝ $626.00High
12/7/2021CitigroupBoost TargetBuy$526.00 ➝ $660.00High
12/7/2021MizuhoBoost TargetNeutral$475.00 ➝ $490.00High
12/7/2021Piper SandlerBoost TargetOverweight ➝ Overweight$525.00 ➝ $585.00High
11/16/2021Credit Suisse GroupInitiated CoverageOutperform$700.00High
11/15/2021MizuhoBoost TargetNeutral$410.00 ➝ $475.00Low
9/17/2021BarclaysBoost TargetOverweight$505.00 ➝ $590.00Medium
9/7/2021ArgusBoost TargetBuy$406.00 ➝ $550.00High
9/3/2021The Goldman Sachs GroupReiterated RatingBuy$475.00N/A
9/3/2021OppenheimerBoost TargetOutperform$400.00 ➝ $470.00High
9/3/2021Morgan StanleyBoost TargetOverweight$410.00 ➝ $480.00High
9/3/2021BarclaysBoost TargetOverweight ➝ Overweight$420.00 ➝ $505.00High
9/3/2021Piper SandlerBoost TargetOverweight$425.00 ➝ $525.00High
9/3/2021Needham & Company LLCBoost TargetBuy$415.00 ➝ $534.00High
9/3/2021Stifel NicolausBoost TargetBuy$384.00 ➝ $495.00High
9/3/2021UBS GroupBoost TargetNeutral$300.00 ➝ $450.00High
9/3/2021MizuhoBoost TargetNeutral$350.00 ➝ $410.00High
9/3/2021CitigroupReiterated RatingBuy$450.00 ➝ $526.00High
8/24/2021Needham & Company LLCInitiated CoverageBuy$415.00Low
8/24/2021Morgan StanleyBoost TargetOverweight$377.00 ➝ $410.00Medium
8/23/2021BarclaysBoost TargetOverweight$390.00 ➝ $420.00Medium
7/14/2021Needham & Company LLCInitiated CoverageBuy$415.00Low
7/14/2021MizuhoBoost TargetNeutral$300.00 ➝ $320.00High
6/4/2021Needham & Company LLCBoost TargetBuy$409.00 ➝ $415.00High
6/4/2021MizuhoBoost TargetPositive ➝ Neutral$265.00 ➝ $300.00High
6/4/2021UBS GroupLower TargetNeutral$325.00 ➝ $300.00High
6/4/2021CitigroupBoost TargetBuy$445.00 ➝ $450.00High
5/25/2021Morgan StanleyLower TargetOverweight$415.00 ➝ $377.00Low
5/14/2021The Goldman Sachs GroupInitiated CoverageBuy$310.00High
5/13/2021MizuhoLower TargetNeutral$320.00 ➝ $265.00High
4/12/2021MizuhoInitiated CoverageNeutral$320.00Medium
3/23/2021UBS GroupInitiated CoverageNeutral$325.00Low
3/12/2021ArgusUpgradeHold ➝ Buy$406.00Medium
3/10/2021Morgan StanleyLower TargetOverweight$439.00 ➝ $415.00High
3/10/2021Needham & Company LLCBoost TargetBuy$394.00 ➝ $409.00High
3/10/2021DA DavidsonBoost TargetPositive ➝ Neutral$275.00 ➝ $300.00High
2/23/2021CitigroupBoost TargetBuy$465.00 ➝ $500.00High
1/19/2021Needham & Company LLCBoost TargetBuy$341.00 ➝ $394.00Low
1/13/2021Smith Barney CitigroupBoost Target$354.00 ➝ $465.00Low
1/11/2021Piper SandlerBoost Target$328.00 ➝ $425.00Medium
1/11/2021BarclaysBoost TargetOverweight$331.00 ➝ $435.00Low
1/6/2021MacquarieInitiated CoverageOutperformN/A
1/5/2021OppenheimerBoost TargetOutperform$300.00 ➝ $400.00N/A
12/17/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$295.00 ➝ $439.00High
12/9/2020DA DavidsonBoost TargetNeutral$250.00 ➝ $275.00High
12/9/2020Piper SandlerBoost TargetOverweight$310.00 ➝ $328.00High
12/9/2020Needham & Company LLCBoost TargetBuy$290.00 ➝ $341.00High
12/7/2020Morgan StanleyBoost TargetEqual Weight$270.00 ➝ $295.00Low
11/18/2020Needham & Company LLCReiterated RatingBuy$290.00Low
10/23/2020BarclaysBoost TargetOverweight$287.00 ➝ $331.00Low
9/24/2020FBN SecuritiesInitiated CoverageOutperform$260.00Low
9/3/2020DA DavidsonBoost TargetNeutral$215.00 ➝ $250.00High
9/3/2020Morgan StanleyBoost TargetEqual Weight$205.00 ➝ $270.00High
9/3/2020Needham & Company LLCBoost TargetBuy$259.00 ➝ $290.00High
9/3/2020Stifel NicolausBoost TargetBuy$225.00 ➝ $320.00High
9/3/2020BarclaysBoost TargetOverweight$280.00 ➝ $287.00High
9/3/2020CitigroupBoost TargetBuy$275.00 ➝ $305.00High
9/3/2020The Goldman Sachs GroupBoost TargetNeutral$215.00 ➝ $245.00High
9/3/2020Piper SandlerBoost TargetOverweight$226.00 ➝ $310.00High
9/2/2020OppenheimerBoost TargetOutperform$240.00 ➝ $275.00High
6/24/2020The Goldman Sachs GroupBoost TargetAverage ➝ Neutral$169.00 ➝ $215.00Low
6/11/2020Morgan StanleyBoost TargetEqual Weight$203.00 ➝ $205.00Low
6/5/2020DA DavidsonBoost TargetNeutral$105.00 ➝ $215.00Medium
6/5/2020Piper SandlerBoost TargetOverweight$138.00 ➝ $226.00High
6/5/2020Monness Crespi & HardtDowngradeBuy ➝ NeutralHigh
6/5/2020OppenheimerReiterated RatingBuy$140.00 ➝ $240.00High
6/2/2020BarclaysBoost TargetOverweight$130.00 ➝ $275.00High
6/2/2020Needham & Company LLCBoost TargetBuy$170.00 ➝ $253.00High
6/1/2020Morgan StanleyBoost TargetEqual Weight$141.00 ➝ $203.00Low
5/28/2020CitigroupBoost TargetBuy$175.00 ➝ $275.00Medium
5/22/2020Stifel NicolausBoost TargetBuy$160.00 ➝ $225.00High
4/27/2020Needham & Company LLCLower TargetBuy$172.00 ➝ $170.00Medium
4/19/2020Stifel NicolausBoost TargetBuy$135.00 ➝ $160.00High
3/18/2020OppenheimerLower Target$155.00 ➝ $140.00High
3/18/2020Piper SandlerLower TargetHigh
3/18/2020DA DavidsonLower TargetNeutral$143.00 ➝ $105.00High
3/18/2020Needham & Company LLCLower Target$189.00 ➝ $172.00High
3/18/2020Monness Crespi & HardtLower TargetBuy$190.00 ➝ $150.00High
3/18/2020CitigroupLower TargetBuy$200.00 ➝ $175.00High
3/18/2020Stifel NicolausLower TargetHold$185.00 ➝ $135.00High
3/16/2020Needham & Company LLCLower TargetPositive ➝ Buy$189.00 ➝ $172.00High
1/27/2020Needham & Company LLCReiterated RatingBuy$189.00Medium
1/13/2020Morgan StanleyBoost TargetEqual Weight$160.00 ➝ $171.00Medium
1/6/2020ArgusInitiated CoverageHoldHigh
12/10/2019Needham & Company LLCReiterated RatingBuy$189.00High
12/10/2019DA DavidsonReiterated RatingNeutral ➝ Positive$143.00High
12/10/2019Morgan StanleyBoost TargetEqual Weight$150.00 ➝ $160.00High
12/10/2019Nomura SecuritiesBoost TargetReduce$76.00 ➝ $78.00High
10/28/2019Piper Jaffray CompaniesInitiated CoverageOverweight$158.00Low
10/16/2019Morgan StanleyLower TargetEqual ➝ Equal Weight$160.00 ➝ $150.00High
10/11/2019OppenheimerLower TargetOutperform$180.00 ➝ $155.00Low
9/6/2019BarclaysReiterated RatingBuyLow
9/5/2019Morgan StanleyBoost TargetEqual Weight$156.00 ➝ $160.00High
9/5/2019BarclaysBoost TargetOverweight$178.00 ➝ $179.00High
9/5/2019Stifel NicolausBoost TargetBuy$180.00 ➝ $185.00High
9/5/2019CitigroupBoost TargetBuy$184.00 ➝ $195.00High
9/5/2019Needham & Company LLCSet TargetBuy$184.00High
9/4/2019KeyCorpSet TargetBuy$188.00Low
8/30/2019Monness Crespi & HardtSet TargetBuy$185.00Low
8/30/2019Stifel NicolausSet TargetBuy$180.00Medium
8/28/2019Morgan StanleyBoost TargetEqual Weight$156.00Medium
8/27/2019CitigroupUpgradeNeutral ➝ Buy$162.00 ➝ $184.00Medium
8/13/2019Compass PointInitiated CoverageNeutral ➝ Neutral$155.00Medium
6/19/2019Nomura SecuritiesSet TargetSell$76.00High
6/19/2019OppenheimerBoost TargetOutperform$160.00 ➝ $180.00Low
6/19/2019DA DavidsonBoost Target$165.00Medium
6/19/2019KeyCorpBoost TargetOverweight$165.00 ➝ $188.00High
6/19/2019William BlairReiterated RatingOutperformHigh
6/19/2019Stifel NicolausBoost TargetBuy ➝ Positive$155.00 ➝ $180.00High
6/7/2019Morgan StanleySet TargetHold$156.00Medium
6/6/2019Nomura SecuritiesBoost TargetReduce$70.00 ➝ $76.00High
6/6/2019DA DavidsonBoost TargetNeutral$140.00High
6/6/2019KeyCorpBoost TargetOverweight$150.00 ➝ $165.00High
6/6/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$150.00 ➝ $185.00High
6/4/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$130.00 ➝ $159.00High
5/31/2019CitigroupSet TargetHold$155.00High
5/23/2019Morgan StanleyBoost TargetEqual Weight$124.00 ➝ $153.00Low
5/15/2019BarclaysBoost TargetOverweight ➝ Overweight$143.00 ➝ $178.00Medium
3/22/2019William BlairInitiated CoverageOutperform ➝ OutperformMedium
3/14/2019CitigroupBoost TargetNeutral ➝ Neutral$94.00 ➝ $116.00High
3/14/2019Stifel NicolausBoost TargetBuy$95.00 ➝ $130.00High
3/14/2019Monness Crespi & HardtBoost TargetBuy$110.00 ➝ $150.00High
3/14/2019DA DavidsonReiterated RatingNeutralHigh
3/14/2019Needham & Company LLCReiterated RatingBuy$108.00 ➝ $130.00High
3/14/2019KeyCorpBoost TargetOverweight ➝ Overweight$100.00 ➝ $150.00High
3/13/2019JMP SecuritiesReiterated RatingHoldHigh
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$91.00 ➝ $108.00Low
2/26/2019Nomura SecuritiesSet TargetSell$63.00Medium
12/14/2018Needham & Company LLCBoost TargetBuy$97.00Low
12/6/2018Needham & Company LLCBoost TargetBuy ➝ Buy$85.00 ➝ $91.00High
12/6/2018CitigroupBoost TargetNeutral ➝ Neutral$86.00 ➝ $94.00High
12/6/2018Monness Crespi & HardtBoost TargetBuy ➝ Buy$90.00 ➝ $110.00High
10/17/2018CIBCInitiated CoverageOutperform ➝ Outperform$80.00Low
10/17/2018OppenheimerInitiated CoverageOutperform$80.00Low
10/2/2018DA DavidsonInitiated CoverageNeutral$80.00Low
10/2/2018Nomura SecuritiesDowngradeNeutral ➝ Reduce$43.00 ➝ $63.00Low
9/17/2018BarclaysBoost TargetOverweight ➝ Overweight$79.00 ➝ $105.00Low
9/12/2018BTIG ResearchInitiated CoverageNeutralLow
9/11/2018CitigroupBoost TargetNeutral ➝ Neutral$56.00 ➝ $86.00Low
9/6/2018Nomura SecuritiesBoost TargetNeutral ➝ Neutral$40.00 ➝ $43.00High
9/6/2018BarclaysReiterated RatingOverweight ➝ Overweight$72.00 ➝ $79.00High
9/6/2018Monness Crespi & HardtBoost TargetBuy ➝ Buy$60.00 ➝ $90.00High
9/6/2018KeyCorpReiterated RatingOverweight ➝ Overweight$62.00 ➝ $88.00High
9/6/2018Stifel NicolausBoost TargetBuy ➝ Buy$53.00 ➝ $80.00High
9/4/2018Needham & Company LLCBoost TargetBuy ➝ Buy$57.00 ➝ $85.00High
8/30/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$41.00 ➝ $66.00Medium
8/15/2018BarclaysBoost TargetOverweight ➝ Overweight$57.00 ➝ $72.00Low
7/9/2018Rosenblatt SecuritiesInitiated CoverageBuyLow
6/28/2018CitigroupInitiated CoverageNeutral$56.00Low
6/12/2018Needham & Company LLCBoost TargetBuy$52.00 ➝ $57.00High
6/7/2018Stifel NicolausBoost TargetBuy ➝ Buy$47.00 ➝ $53.00Low
6/7/2018KeyCorpBoost TargetOverweight ➝ Overweight$50.00 ➝ $62.00Low
6/7/2018Monness Crespi & HardtBoost TargetBuy$51.00 ➝ $60.00Low
6/7/2018BarclaysBoost TargetOverweight ➝ Overweight$47.00 ➝ $57.00High
6/5/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$35.00 ➝ $38.00Medium
6/5/2018Nomura SecuritiesBoost TargetNeutralMedium
6/4/2018Needham & Company LLCBoost TargetBuy$43.00 ➝ $52.00High
5/14/2018KeyCorpInitiated CoverageOverweight ➝ Overweight$50.00Medium
4/11/2018Monness Crespi & HardtInitiated CoverageBuy ➝ Buy$51.00Low
4/5/2018BarclaysBoost TargetOverweight ➝ Overweight$45.00 ➝ $47.00Low
3/14/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$32.00 ➝ $35.00High
3/14/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$34.00 ➝ $43.00High
3/14/2018Stifel NicolausBoost TargetBuy ➝ Buy$34.00 ➝ $43.00High
3/14/2018BarclaysBoost TargetOverweight ➝ Overweight$38.00 ➝ $45.00High
2/14/2018Needham & Company LLCUpgradeHold ➝ Buy$34.00High
1/30/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$33.00 ➝ $32.00High
1/23/2018Nomura SecuritiesInitiated CoverageNeutral ➝ Neutral$30.00High
11/15/2017Canaccord Genuity GroupInitiated CoverageBuy$35.00N/A
11/13/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$24.00 ➝ $31.00N/A
11/13/2017Stifel NicolausInitiated CoverageBuy ➝ Buy$34.00N/A
11/13/2017JMP SecuritiesInitiated CoverageMkt Perform ➝ Market PerformN/A
11/13/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$30.00N/A
11/13/2017BarclaysInitiated CoverageOverweight ➝ Overweight$38.00N/A
10/23/2017Needham & Company LLCInitiated CoverageHold ➝ HoldN/A
(Data available from 10/3/2017 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
3/7/2022
  • 6 very positive mentions
  • 26 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
4/6/2022
  • 7 very positive mentions
  • 37 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
5/6/2022
  • 4 very positive mentions
  • 26 positive mentions
  • 10 negative mentions
  • 0 very negative mentions
6/5/2022
  • 8 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
7/5/2022
  • 1 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/4/2022
  • 6 very positive mentions
  • 36 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
9/3/2022
  • 4 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/3/2022

Current Sentiment

  • 4 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
MongoDB logo
MongoDB, Inc. provides general purpose database platform worldwide. The company offers MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $193.49
Low: $186.07
High: $200.48

50 Day Range

MA: $289.37
Low: $189.69
High: $380.31

52 Week Range

Now: $193.49
Low: $188.17
High: $590.00

Volume

83,603 shs

Average Volume

1,565,086 shs

Market Capitalization

$13.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

Frequently Asked Questions

What sell-side analysts currently cover shares of MongoDB?

The following Wall Street sell-side analysts have issued reports on MongoDB in the last twelve months: Barclays PLC, Canaccord Genuity Group Inc., Citigroup Inc., Credit Suisse Group AG, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Redburn Partners, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Inc., Tigress Financial, Truist Financial Co., UBS Group AG, and William Blair.
View the latest analyst ratings for MDB.

What is the current price target for MongoDB?

18 Wall Street analysts have set twelve-month price targets for MongoDB in the last year. Their average twelve-month price target is $372.39, suggesting a possible upside of 92.5%. Tigress Financial has the highest price target set, predicting MDB will reach $630.00 in the next twelve months. Redburn Partners has the lowest price target set, forecasting a price of $190.00 for MongoDB in the next year.
View the latest price targets for MDB.

What is the current consensus analyst rating for MongoDB?

MongoDB currently has 1 sell rating and 18 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDB will outperform the market and that investors should add to their positions of MongoDB.
View the latest ratings for MDB.

What other companies compete with MongoDB?

How do I contact MongoDB's investor relations team?

MongoDB's physical mailing address is 1633 BROADWAY 38TH FLOOR, NEW YORK NY, 10019. The company's listed phone number is (646) 727-4092 and its investor relations email address is [email protected] The official website for MongoDB is www.mongodb.com. Learn More about contacing MongoDB investor relations.